Table 1.
Region | Minimal requirement | Total liver volume | |
---|---|---|---|
Normal liver | |||
Vauthey et al. 7 | USA | 25% | Formula-based liver volume* |
Shoup et al. 21 | USA | 25% | CT-based non-tumor liver volume |
Shindle et al. 22 | Europe | 26.6% | CT-based non-tumor liver volume |
Kishi et al. 23 | USA | 20% | Formula-based liver volume† |
Injured liver (chronic hepatitis/cirrhosis and chemotherapy) | |||
Kubota et al. 8† | Asia | 40% or 50%‡ | CT-based non-tumor liver volume |
Shirabe et al. 24 | Asia | 250mL/m2§ | NA |
Azoulay et al.17 | Europe | 40%¶ | CT-based non-tumor liver volume |
Shindoh et al. 25 | USA | 30%∥ | Formula-based liver volume† |
Abbreviations: CT, computed tomography; NA, not applicable.
(Standardized liver volume) = 706.2×(body surface area) + 2.4 by Urata K, et al. 93
(Standardized liver volume) = −794 + 1267.28×(body surface area) by Vauthey JN, et al.94
Based on indocyanine green retention rate at 15 minutes.
Categorized as injured liver based on cohort of patients with hepatocellular carcinoma.
Fibrosis or cirrhosis
Chemotherapy > 3 months